FDA Drug Shortage Database
Ropivacaine (Naropin) shortage
The FDA Drug Shortage Database lists 15 of 49 ropivacaine presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on March 23, 2018. 34 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 2mg/1ml injection | 8 | 13 | 0 |
| 5mg/1ml injection | 3 | 13 | 0 |
| 7.5mg/1ml injection | 2 | 1 | 0 |
| 10mg/1ml injection | 2 | 7 | 0 |
Which presentations are listed?
Limited or unavailable now (15)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Demand increase for the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Demand increase for the drug |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | InfoRLife SA | Current posted March 27, 2018, updated August 18, 2026 | Limited Availability; Other |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | InfoRLife SA | Current posted March 27, 2018, updated October 6, 2026 | Unavailable; Other |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) | Caplin Steriles, Ltd. | Current posted December 22, 2020, updated June 10, 2026 | Limited Availability; Other |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Unavailable; Demand increase for the drug |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) | Caplin Steriles, Ltd. | Current posted December 22, 2020, updated June 10, 2026 | Limited Availability; Other |
| Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (34)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Caplin Steriles, Ltd. | Current posted December 22, 2020, updated June 10, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | InfoRLife SA | Current posted March 27, 2018, updated October 6, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | InfoRLife SA | Current posted March 27, 2018, updated October 6, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | InfoRLife SA | Current posted March 27, 2018, updated October 6, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | InfoRLife SA | Current posted March 27, 2018, updated October 6, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Caplin Steriles, Ltd. | Current posted December 22, 2020, updated June 10, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Eugia US LLC | Current posted March 23, 2018, updated October 2, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Somerset Therapeutics, LLC | Current posted March 23, 2018, updated September 11, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage